Waters Corporation Launches the Waters® SYNAPT™ MS System

Waters Corporation has launched the Waters® SYNAPT™ MS system, a next-generation quadrupole orthogonal acceleration, time-of-flight (oa-Tof) mass spectrometry (MS) platform.

SYNAPT MS is a key part of Waters' strategy to enhance the quality and productivity of life science and drug discovery and development workflows.

Additionally, the SYNAPT MS system can provide an upgrade pathway to the SYNAPT High Definition MS™ (HDMS™) system, enabling researchers to analyze samples differentiated by size, shape and charge, as well as mass, ultimately providing new capabilities that can help them meet and exceed future requirements, the company says.

“Confident sample identification, detailed characterization and increased productivity are primary requirements for intelligent mass spectrometry-based solutions in key biomedical applications such as proteomics, metabonomic profiling, biomarker discovery/validation and pharmaceutical R&D,” said Brian W. Smith, Vice President, Mass Spectrometry Operations for the Waters Division.

“The new SYNAPT MS meets these demands through application specific system solutions designed to help our customers accelerate and improve the quality of laboratory analysis with the goal of advancing research and reducing time-to-market.”

SYNAPT MS is a central component of Waters' system level solutions - combining ACQUITY UltraPerformance LC® (UPLC®)separations, Exact Mass MSE data acquisition and ‘chemically intelligent’ MassLynx™ Informatics - designed to generate data from complex biological samples, maximize confidence in results and enable scientists to make better informed decisions.